Results 61 to 70 of about 406 (135)
Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial [PDF]
Background. Non-pharmacological treatments based on collagen as a dietary supplement are emerging as a new area of interest to support preventive or therapeutic effects in patients with osteoarthritis (OA). Aim.
Liudmila I. Alekseeva +18 more
doaj +1 more source
The paper deals with an update on biologically active additives (BAAs) and emphasizes their role in normalizing and/or improving the functional status of organs and systems, including the gastrointestinal tract microflora, in reducing the risk of ...
I. S. Dydykina +4 more
doaj +1 more source
<p class="abstract">Osteoarthritis (OA) is the most common joint disease affecting millions worldwide. Osteoarthritis typically affects the knees, hands, hips, and feet. It is characterized by complex pathologic changes in cartilage which haven’t been fully elucidated yet.
Karun Jain +4 more
openaire +2 more sources
This study aims to extract pepsin soluble collagen from sturgeon cartilage, hydrolyze to collagen peptides and prepare SCCP nanoliposomes to explore the treatment effects of osteoarthritis in rats. ABSTRACT This study aims to extract pepsin soluble collagen (PSC) from sturgeon cartilage, hydrolyze to sturgeon cartilage collagen peptides (SCCP), and ...
Chia‐Chi Kung +2 more
wiley +1 more source
In 2021, an article was published comparing two commercial products containing undenatured type II collagen: b-2Cool® (Bioiberica, S.A.U., Barcelona, Spain; designated CII-X, X1, and X2) and UC-II (Lonza Consumer Health Inc, USA; designated CII-Y, Y1, and Y2). However, we feel certain concerns remain where clarification may be warranted.
openaire +2 more sources
Collagen from eggshell membrane (EM) was stabilized via a cross‐linking procedure using microbial transglutaminase as an alternative, nontoxic cross‐linking reagent for its low stability and low mechanical strength. The physicochemical features of collagen solutions (5 mg/mL), which were cross‐linked by different concentrations of MTG (30, 40, 50, 60 ...
Elahe Kazemi Kheirabadi +4 more
wiley +1 more source
Evidence base of pharmaconutraceuticals with chondroprotective action
Background. Osteoarthritis is one of the most common chronic diseases of the musculoskeletal system worldwide, being a common cause of chronic pain syndrome and disability.
O. A. Shavlovskaya +2 more
doaj +1 more source
Osteoartritis merupakan penyakit sendi yang paling sering dialami oleh manusia, terutama lutut. Osteoartritis lutut terjadi sekitar 15,5% pada pria dan 12,7% pada wanita di Indonesia.
Muhammad Yamin, D Henky Lesmana
doaj +1 more source
A Literature Review of Undenatured type II collagen (UC-II) in Joint Health and Disease
Undenatured type II collagen (UC-II) is supplementary which is from chicken sternum cartilage. (Lugo, J. P., Saiyed,…,2015) UC-II has undenatured type II collagen componentand. The safety and capability of UC-II in adjusting joint discomfort in Osteoarthritis and Rheumatoid arthritis support by previous preclinical and clinical studies. (Lugo, J.
openaire +2 more sources
Current evidence for non‐pharmaceutical, non‐surgical treatments of canine osteoarthritis
Osteoarthritis is a progressive degenerative disease process that affects a significant proportion of the canine population, impacting these animals' quality of life. Currently, there is no cure and treatment consists of managing the clinical signs of pain and reduced mobility.
C. Pye +4 more
wiley +1 more source

